Top Markets
Coin of the day
Pangaea Oncology, S.A. Pangaea Oncology, S.A.

Pangaea Oncology, S.A.

PANG
Κατάταξη σε μετοχές #24020
Pangaea Oncology, S.A. delivers essential medical services to cancer patients... Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
Τιμή μετοχής
$1.84
Τελευταίος συγχρονισμός: 2026-08-21
Κεφαλαιοποίηση
$66.03M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
-8.25%
Χώρα
ES
Εμπόριο Pangaea Oncology, S.A. (PANG)

Κατηγορία

Ιστορικό τιμής μετοχής για την Pangaea Oncology, S.A. (PANG)
Υψηλότερη τιμή κλεισίματος: $1.84 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $2.93 στις 2017-09-01
Ιστορικό τιμής μετοχής της Pangaea Oncology, S.A. από 2017 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -2.66%
2025 8.06%
2024 15.26%
2023 2.98%
2022 -25.56%
2021 6.89%
2020 3.56%
2019 -27.13%
2018 -12.00%
2017 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$628.91 25.78%
US
$219.26 3.52%
US
$23.60 79.96%
CN
$331.56 100.22%
US
$159.25 30.93%
US